JP Morgan Chase
BBP icon

JP Morgan Chase’s Virtus Biotech ETF BBP Stock Holding History

JP Morgan Chase’s Portfolio BBP Stock Details BBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-100
Closed -$6.28K – 7393
2024
Q3 		$6.28K Buy
100
+90
+900% +$5.6K ﹤0.01% 6447
2024
Q2 		$588 Buy
+10
New +$557 ﹤0.01% 6672
2019
Q3 		– Sell
-4,260
Closed -$172K – 5715
2019
Q2 		$172K Buy
4,260
+843
+25% +$34.7K ﹤0.01% 4720
2019
Q1 		$153K Sell
3,417
-313
-8% -$13.1K ﹤0.01% 4731
2018
Q4 		$130K Sell
3,730
-10
-0.3% -$381 ﹤0.01% 4743
2018
Q3 		$169K Sell
3,740
-87
-2% -$3.89K ﹤0.01% 4748
2018
Q2 		$168K Sell
3,827
-64
-2% -$2.71K ﹤0.01% 4634
2018
Q1 		$161K Buy
3,891
+37
+1% +$1.56K ﹤0.01% 4437
2017
Q4 		$156K Buy
3,854
+275
+8% +$11K ﹤0.01% 4513
2017
Q3 		$147K Buy
3,579
+516
+17% +$20.6K ﹤0.01% 4201
2017
Q2 		$121K Buy
3,063
+807
+36% +$30.1K ﹤0.01% 4113
2017
Q1 		$85K Buy
+2,256
New +$82.6K ﹤0.01% 4378

Other funds holding BBP

CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
IFG
Independent Financial Group San Diego, California $5.35B AUM 43.78% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
JCM
Jag Capital Management St Louis, Missouri $889M AUM 42.63% 1-Year Est. Return
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return
Carson Wealth (CWM LLC)
Carson Wealth (CWM LLC) Omaha, Nebraska $38.1B AUM 19.66% 1-Year Est. Return

JP Morgan Chase's BBP Position: Q4 2024 in Review

JP Morgan Chase sold out of Virtus Biotech ETF (BBP) in Q4 2024, closing a stake of 100 shares — an estimated $6.28K sold.

JP Morgan Chase first reported a position in BBP in Q1 2017 and held it in 12 quarters. The position peaked at $172K in Q2 2019. 13 funds tracked by Wall St. Rank hold BBP as of Q4 2024.

  • JP Morgan Chase reported no remaining Virtus Biotech ETF position as of Q4 2024 after selling out during the quarter.
  • JP Morgan Chase sold 100 Virtus Biotech ETF shares in Q4 2024, an estimated $6.28K.
  • JP Morgan Chase first reported a position in Virtus Biotech ETF in Q1 2017 and held it in 12 quarters.
  • JP Morgan Chase's Virtus Biotech ETF position peaked at $172K in Q2 2019.
  • 13 funds tracked by Wall St. Rank held Virtus Biotech ETF as of Q4 2024.

Based on JP Morgan Chase's 13F filing for Q4 2024, filed 12 Feb 2025.